Together our studies suggested that TRPM8 is a key element of the orphan pathway of non-genomic testosterone-induced responses, and its activity may significantly contribute to anti-tumor defense mechanism and could serve as a novel therapeutic target. This evidence concerns the gene TRPM8 and neoplasm.